MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 21, 2006; DOI: 10.1124/mol.106.023184


0026-895X/06/7001-348-355$20.00
Mol Pharmacol 70:348-355, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.106.023184v1
70/1/348    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Centerwall, C. R.
Right arrow Articles by Dabrowiak, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Centerwall, C. R.
Right arrow Articles by Dabrowiak, J. C.

Modification and Uptake of a Cisplatin Carbonato Complex by Jurkat CellsFormula

Corey R. Centerwall, Kirk A. Tacka1, Deborah J. Kerwood, Jerry Goodisman, Bonnie B. Toms, Ronald L. Dubowy, and James C. Dabrowiak

Department of Chemistry, Syracuse University, Syracuse, New York (C.R.C., K.A.T., D.J.K., J.G., J.C.D.); and Department of Pediatrics, Upstate Medical University, State University of New York, Syracuse, New York (B.B.T., R.L.D.)

The interactions of Jurkat cells with cisplatin, cis-[Pt(15NH3)2Cl2](1), are studied using 1H-15N heteronuclear single quantum coherence (HSQC) NMR and inductively coupled plasma mass spectrometry. We show that Jurkat cells in culture rapidly modify the monocarbonato complex cis-[Pt(15NH3)2(CO3)Cl]- (4), a cisplatin species that forms in culture media and probably also in blood. Analysis of the HSQC NMR peak intensity for 4 in the presence of different numbers of Jurkat cells reveals that each cell is capable of modifying 0.0028 pmol of 4 within ~0.6 h. The amounts of platinum taken up by the cell, weakly bound to the cell surface, remaining in the culture medium, and bound to genomic DNA were measured as functions of time of exposure to different concentrations of drug. The results show that most of the 4 that has been modified by the cells remains in the culture medium as a substance of molecular mass <3 kDa, which is HSQC NMR silent, and is not taken up by the cell. These results are consistent with a hitherto undocumented extracellular detoxification mechanism in which the cells rapidly modify 4, which is present in the culture medium, so it cannot bind to the cell. Because there is only a slow decrease in the amount of unmodified 4 remaining in the culture medium after 1 h, -1.1 ± 0.4 µM h-1, the cells subsequently lose their ability to modify 4. These observations have important implications for the mechanism of action of cisplatin.


Received for publication February 2, 2006.

Accepted for publication April 19, 2006.

Address correspondence to: Dr. James C. Dabrowiak, Department of Chemistry, 111 College Place, Rm. 1-014 CST, Syracuse University, Syracuse, NY 13244-4100. E-mail: jcdabrow{at}syr.edu




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. N. Bose, L. Maurmann, R. J. Mishur, L. Yasui, S. Gupta, W. S. Grayburn, H. Hofstetter, and T. Salley
Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells
PNAS, November 25, 2008; 105(47): 18314 - 18319.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics